VIE Equity Snapshot

REC Weekly Equity Report

Recordati Industria Chimica e Farmaceutica S.p.A.

Interactive chart JSON snapshot
Latest Close 51.00 EUR 12 Jun 2026
1W Return 0.4% latest completed week
4W Return -0.1% short-term follow-through
12W Return 15.4% quarterly tape
Trend Breadth 21.2% 11 of 52 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing's syndrome; Cystadrops treatment of the ocular manifestations of cystinosis; Carbaglu for hyperammonemia due to n-acetyl glutamate synthase deficiency; Qarziba for neuroblastoma patients and patients with relapsed or refractory neuroblastoma; and Fotivda for renal cell carcinoma. It also develops Sylvant …

Snapshot

What the weekly tape is saying

REC closed the latest completed week at 51.00 EUR. The 4-week return is -0.1% and the 12-week return is 15.4%. Trend Signal is active, Market Dynamics is 1.13. Setup signature: Risk-first tape with a 40/100 composite read.

Trend Signal Active
Market Dynamics No fresh buy
Price vs Trend 5.4%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 25 Persistence of active Trend Signal over the last year and current streak.
Momentum 64 Blend of 4-week and 12-week follow-through.
Dynamics 71 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 78 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
48.39 EUR
Vs Trend Line
5.4%
Fair Value
47.99 EUR
Vs Fair Value
6.3%
52W High
53.53 EUR
52W Low
43.38 EUR
Drawdown
-4.7%
Range Position
75.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 0.4%
4W -0.1%
12W 15.4%
26W 7.5%
52W -4.2%

Trend read

Active Streak
4 weeks
52W Active Weeks
11
52W Active Breadth
21.2%
Sector Scope
AT Healthcare
Sector Rank
37 of 112
Sector Percentile
67.6%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
1.13
4W MD Change
7.8%
Relative Strength
-16.20
4W RS Change
-27.0%
Expectation
Positive
Probability
55.49%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
243
52W Average
99
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.0%
52W Volatility
2.7%
Upside Weeks
26
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
2.0% / -2.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
VIE
Country
AT
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
EUR
Market Cap
10.4B

Opportunity signals

  • Trend Signal is active with a 4-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • No major top-level risk cluster is currently dominant.

Watch next

  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 51.00 EUR 0.4% 48.39 EUR 47.99 EUR 1.13 -16.20 0 On
5 Jun 2026 50.80 EUR -0.9% 48.38 EUR 47.93 EUR 1.17 -14.82 0 On
29 May 2026 51.25 EUR -0.2% 48.30 EUR 47.87 EUR 1.20 -15.55 0 On
22 May 2026 51.35 EUR 0.6% 48.27 EUR 47.80 EUR 1.14 -13.57 410 On
15 May 2026 51.04 EUR 2.7% 48.24 EUR 47.72 EUR 1.05 -12.75 0 Off
8 May 2026 49.71 EUR 2.0% 48.22 EUR 47.66 EUR 0.97 -15.76 0 Off
1 May 2026 48.72 EUR -1.3% 48.27 EUR 47.59 EUR 0.89 -16.69 0 Off
24 Apr 2026 49.36 EUR -0.2% 48.37 EUR 47.52 EUR 0.96 -15.62 0 Off
17 Apr 2026 49.46 EUR 2.9% 48.36 EUR 47.45 EUR 0.91 -18.85 0 Off
10 Apr 2026 48.07 EUR -2.7% 48.44 EUR 47.37 EUR 0.43 -19.71 205 Off
3 Apr 2026 49.41 EUR 2.3% 48.60 EUR 47.30 EUR 0.05 -12.70 1.4K Off
27 Mar 2026 48.31 EUR 9.3% 48.70 EUR 47.21 EUR -0.32 -12.28 1.1K Off
20 Mar 2026 44.21 EUR -2.5% 48.81 EUR 47.13 EUR -0.55 -19.00 0 Off
13 Mar 2026 45.35 EUR -2.7% 49.04 EUR 47.08 EUR -0.45 -18.51 0 Off